NUVL 外匯新聞
Nuvalent Promotes Henry Pelish To Chief Scientific Officer
Biopharmaceutical company Nuvalent, Inc. (NUVL) announced Thursday that Henry Pelish has been promoted to Chief Scientific Officer. In this role, Pelish will continue to oversee discovery and early-stage development activities. He currently serves as Senior Vice President, Drug Discovery.
RTTNews
|
112天前
